Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
June 2021
in “
Dermatology and Therapy
”
androgen-mediated sebogenesis hyperkeratinization Cutibacterium acnes interleukins IL-1β IL-17 IL-23 tumor necrosis factor alpha TNFα insulin growth factor 1 IGF-1 sebocyte activity microbiome pro-inflammatory cytokines hypertrophic scar keloid scarring TGFβ IL-6 MMP androgen sebaceous glands acne bacteria biological antibodies cytokines growth factor skin microbiome scar treatment
Studysummary This study highlights the evolving understanding of acne's pathophysiology and suggests that targeting pro-inflammatory cytokines such as IL-1β, IL-17, IL-23, and TNFα with biological antibodies may offer new treatment strategies for severe acne and its scars.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer